We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05052528
Brief Title: Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

First Submitted : September 13, 2021
First Submitted that Met QC Criteria : September 13, 2021
First Posted : September 22, 2021

Last Update Submitted that Met QC Criteria : March 8, 2022
Last Update Posted : March 10, 2022